What is better Brainmint or isolved? If you need to get a convenient way to learn which Learning Management Systems (LMS) product is better, our proprietary algorythm gives Brainmint a score of 8.0 and isolved a score of 6.9 for overall quality and performance. In addition, Brainmint is rated at N/A%, while isolved is rated N/A% for their user satisfaction level.
You can also assess their product details, such as functions, tools, options, plans, prices, and others. See whether the solution lets you to customize a few of its processes to make sure the app complements your own business processes.
Right now, the most significant solutions in our Corporate LMS Software category are: Docebo, TalentLMS, Graphy.
Brainmint is a corporate learning/training application built and optimized for mobile devices that allow organizations to deliver timely and high-quality learning materials to their mobile workforce.
Please note that even though both Brainmint and isolved may provide an outstanding set of features each solution might be aimed at a different business size. If you are comparing features you may want to pay attention to a company size they are aimed at. Some elements could scale up effectively for huge enterprises but if you own a small or medium company it’s usually better to refrain paying for complex features that you may never actually use.
Page last modified
Why is FinancesOnline free?
FinancesOnline is available for free for all business professionals interested in an efficient way to find top-notch SaaS solutions. We are able to keep our service free of charge thanks to cooperation with some of the vendors, who are willing to pay us for traffic and sales opportunities provided by our website. Please note, that FinancesOnline lists all vendors, we’re not limited only to the ones that pay us, and all software providers have an equal opportunity to get featured in our rankings and comparisons, win awards, gather user reviews, all in our effort to give you reliable advice that will enable you to make well-informed purchase decisions.
